ir-be-SAR-tan 
Therapeutic Classification: antihypertensives
Pharmacologic Classification: angiotensin II receptor antagonists
Absorption: 60–80% absorbed following oral administration.
Distribution: Crosses the placenta.
Protein Binding: 90%.
Metabolism/Excretion: Some hepatic metabolism; 20% excreted in urine, 80% in feces.
Half-life: 11–15 hr.
Contraindicated in:
Use Cautiously in:
CV: chest pain, edema, hypotension, tachycardia.
Derm: rash.
F and E: hyperkalemia.
GI: abdominal pain, diarrhea, dyspepsia, nausea, vomiting.
GU: impaired renal function.
MS: pain.
Neuro: anxiety, dizziness, fatigue, headache.
Misc: ANGIOEDEMA.
Drug-Drug:
(Generic available)
NDC Code*